Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Other Non-Current Assets (2016 - 2025)

Altimmune (ALT) has disclosed Other Non-Current Assets for 16 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets fell 9.89% to $1.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.5 million, a 9.89% decrease, with the full-year FY2024 number at $1.6 million, up 351.52% from a year prior.
  • Other Non-Current Assets was $1.5 million for Q3 2025 at Altimmune, down from $1.6 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.7 million in Q2 2024 to a low of $115300.0 in Q1 2021.
  • A 5-year average of $919475.9 and a median of $811000.0 in 2022 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 968.76% in 2021, then plummeted 45.24% in 2024.
  • Altimmune's Other Non-Current Assets stood at $872000.0 in 2021, then decreased by 29.47% to $615000.0 in 2022, then plummeted by 40.98% to $363000.0 in 2023, then skyrocketed by 351.52% to $1.6 million in 2024, then dropped by 8.79% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for ALT's Other Non-Current Assets are $1.5 million (Q3 2025), $1.6 million (Q2 2025), and $1.6 million (Q1 2025).